MHLW To Expand Drug Application Consultation Services July 1, But With A Price Tag For Industry
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan's Ministry of Health, Labor and Welfare established a panel to improve the Pharmaceuticals and Medical Devices Agency's consultation services as one measure to eliminate Japan's drug and medical device lag, and the agency is expected to expand the range and number of consultations starting this year